We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Novel Diagnostic Technique Could Revolutionize Identification of Pathogens in Biological Samples

By LabMedica International staff writers
Posted on 26 Apr 2023

In cases where a patient suffers from an infection, particularly in their bloodstream, traditional methods can take up to seven days to identify pathogens. More...

This delay impedes prompt and accurate diagnosis and treatment, negatively affecting the patient's prognosis. A similar lag occurs in cell therapy product manufacturing, where it can take seven to 14 days to detect contaminants like bacteria, viruses, and fungi. As cell therapy products cannot be sterilized, early contaminant detection is crucial to restart the production cycle, ensuring the safe and prompt delivery of these products to patients.

A research team from the Singapore-MIT Alliance for Research and Technology (SMART, Singapore) is developing an innovative diagnostic method capable of quickly identifying low-abundance pathogens in biological samples. In prior research, the team developed electrostatic microfiltration as an efficient sample preparation device for bacteria enrichment. Their current goal is to integrate this microfilter with mainstream detection methods, allowing for bacterial detection using digital loop-mediated isothermal amplification—a type of polymerase chain reaction (PCR). The resulting system will be fast, single-use, portable, and user-friendly, eliminating the need for a highly specialized facility. Additionally, it will be compatible with other advanced downstream detection techniques and can easily be incorporated into existing commercial kits or facilities to enhance detection method performance.

“This project builds on on-going projects at SMART focused on separating viruses and bacteria – which are much smaller than mammalian cells – from biological samples, and could revolutionize the way pathogens are identified,” said Dr. Yaoping Liu, Senior Postdoctoral Associate at SMART CAMP, who is leading the research team. “The use of an efficient and relatively cost-effective method could significantly improve the prognosis of sepsis and other infectious diseases, and allow the delivery of timely and more personalized care.”

Related Links:
SMART 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.